Adverum Biotechnologies Inc (NASDAQ:ADVM)

1.59
Delayed Data
As of 4:00pm ET
 +0.05 / +3.25%
Today’s Change
1.54
Today|||52-Week Range
14.79
-9.66%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Adverum Biotechnologies Inc have a median target of 5.00, with a high estimate of 6.00 and a low estimate of 4.00. The median estimate represents a +214.47% increase from the last price of 1.59.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Hold stock in Adverum Biotechnologies Inc. This rating has held steady since November, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.34
Sales
$0.00
Reporting Date
Mar 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 11.97%
 
 
 
 
 
 
Growthannually -7.25%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.